DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.

Dexcom's CGM and Abbott's FreeStyle Libre are ... sugar data that can't be captured by only using a traditional glucose meter ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Technology has come a long way since the first blood glucose meter was developed by Anton ... with 2.5 million rings sold globally. Dexcom meanwhile currently occupies around 74% of the CGM ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company ...

DexCom Option Volume And Open Interest Over ... CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide ...

Two excellent examples are DexCom (NASDAQ: DXCM) and Vertex Pharmaceuticals (NASDAQ: VRTX). EDINBURGH, Scotland & SAN DIEGO, March 19, 2025--DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose ...

DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is working on a written response. The diabetes devices ...

Bengaluru: Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its ...